Europe PMC is an archive of life sciences journal literature.
Soheila AJDARY, Ph.D., Institut Pasteur International Network, Paris, Pasteur Institute of Iran
Mechanism of OMCP-mutIL-2 Signalling in NKG2D-Expressing Cells.: (a)
Molecular reshaping of phage-displayed Interleukin-2 at beta chain receptor interface to obtain potent super-agonists with improved developability profiles
A Chemoimmunotherapy Nanogel Enables Efficient Delivery of
Application of IL-2 therapy to target T regulatory cell function: Trends in Immunology
The IL-2A receptor pathway and its role in lymphocyte differentiation and function - ScienceDirect
Yeganeh Talebkhan's research works
Biology of IL‐2 and its therapeutic modulation: Mechanisms and strategies - Mitra - 2018 - Journal of Leukocyte Biology - Wiley Online Library
IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy - ScienceDirect
PDF) Efficacy and antitumor activity of a mutant type of interleukin 2
PDF) Bipolar Neutrosophic Dombi Aggregation Operators With
PDF) Efficacy and antitumor activity of a mutant type of interleukin 2
farhad riazi rad - Academia.edu
Ligand-induced type II interleukin-4 receptor dimers are sustained by rapid re-association within plasma membrane microcompartments
,aspect=fit)
